Stage Ii Testicular Cancer: Disease Bioinformatics
Testicular Cancer is when malignant cancer cells develop in one or both of the testicles in the germ cells. Testicular cancer is the most common cancer in men between the ages of 20-35 years old and is most commonly found in Caucasian men. Risk for developing testicular cancer are having an undescended testicle, family history, and abnormal development of the testicles. There are two main types of testicular cancers: seminomas and nonseminomas. Nonseminomas grow more rapidly and are less sensitive to radiation compared to seminomas. Testicular cancer can spread throughout the body through the tissues, the lymph system, and the blood. Stage II testicular cancer is divided into three subdivisions: stage IIA, stage IIB, and stage IIC. In stage IIA, the cancer has spread up to five lymph nodes in the abdomen, but none are larger than 2 cm. In stage IIB, cancer has spread to no more than five lymph nodes in the abdomen, and at least one lymph node is larger than 2 cm but does not exceed 5 cm. Additionally, stage IIB can be characterized as a spread to more than five lymph nodes yet none are larger than 5 cm. In stage IIC, the cancer has spread to a lymph node and is larger than 5 cm. In all cases, tumor marker levels will remain normal or slightly elevated.
Stage Ii Testicular Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Ii Testicular Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 391 products for the study of Stage Ii Testicular Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.